1D·

Hims: Announcement from Novo Nordisk?

$NOVO B (+1,06 %) Ozempic and Wegovy is offered through Costco with a price tag of $499, still more expensive than Hims' $199 offering.

Of course this is bad news, but the market is growing and it still can't be served properly...

In addition $HIMS (-8,64 %) not only GLP-1 I always normalize these sales from my analyses!

14 Comentarios

Konstantin@Konstantin85

However, HIMS are compounded versions with dose variation and these are not recommended by the FDA and there is even a warning that impurities could occur. In terms of liability, even doctors can be held responsible, as well as the pharmacy and the laboratory. All very complicated compared to tested products from Novo and ELi Lilly. Personally, I don't see the grits from HIMS as a direct competitor to NOVO, but as a kind of TEMU for medicines. There have already been deaths in the USA. Of course, everything has yet to be proven, but when preparations are offered so cheaply, the quality usually suffers. If the regulators turn to telehealth providers regarding liability, then good night HIMS.

•

Daninvest34@Daninvest34

@Konstantin85 hims is not a GLP 1 company.

••

Konstantin@Konstantin85

@Daninvest34 definitely. Neither does Novo ;)

••

user0e3jddwsjxu@user1d7gf8465j461735

What is your target price for $HIMS and could you get in now? I currently have some capital to invest

•

Chris@Multibagger

@user1d7gf8465j461735 I had them too, I got out pretty much exactly at the peak with almost 100%. My re-entry price is below €40, better than €35

•

user0e3jddwsjxu@user1d7gf8465j461735

@Multibagger Thank you very much 👍🏼 I have a quick question, how do you go about finding the next tenbagger? I actually only look at potential candidates through your ideas, but they have often already done well. Which websites/apps do you use for stock analysis? Thank you in advance 👏🏼👍🏼

•

Chris@Multibagger

@user1d7gf8465j461735 There is no short answer to this short question. I use Investing Pro. But above all, I invest money in paid stock reports when they appear on sectors or companies that seem lucrative to me. I'm generally not willing to spend an infinite amount of time researching these companies myself. Otherwise, I spend a lot of time looking at fundamental data on the economy in different regions and what impact this has or could have on certain companies in the future.

•

Yasin21@Yasin21

@Multibagger Are there any reports that you can recommend?

•

Chris@Multibagger

@Yasin21 I sometimes take the ones from Börsenmedien AG. Or also 13F reports. Momentum Mover, Hebel Trader, but all not regularly, but depending on interest

••

Yasin21@Yasin21

@Multibagger 1xx€, is the number worth it?😀😅

•

Chris@Multibagger

@Yasin21 You can get Leverage Trader daily or not for 10€. Whether it's worth it depends on what you expect. You can also do all the research yourself. If I calculate the hours it costs me with an hourly wage, it's more expensive. But everyone has to calculate that for themselves and you have to be able and willing to afford it. I spend around €1000 - €1500 per year. So far I've made more than that. And many recommendations are still ongoing. The reports on commodities in particular are often interesting and I could never research them in such detail.

•

Yasin21@Yasin21

@Multibagger If you had to choose one, which leaf would it be? I'll give it a try!

•

Chris@Multibagger

@Yasin21 if you can invest at least 2-3 k per trade, use the Kirchhoff system. Very high hit rates, but high frequency, as his goal is always to make 10% as quickly as possible and then sell. Since I can never invest more than 300-500 per trade, it wasn't worth it for me.

•

Yasin21@Yasin21

@Multibagger so I have between 1.500€-7000€ invest per position, I think I'll take a look at it, thanks a lot!

••